RxDoctor Payments Data

Elizabeth Montgomery, MD

Anatomic Pathology & Clinical Pathology · Miami, FLNPI 1922050699

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $30,271 of the $31,704 with a category attached, or 95.5%. Olympus Corporation accounts for 60.8% of it on its own, with 5 other manufacturers making up the rest. Among anatomic pathology & clinical pathology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,704in general payments, 2019–2025

Across 29 payments — averaging $1093.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation$19K
  • Janssen Research & Development, LLC$7K
  • AstraZeneca$2K
  • Merck$2K
  • Olympus Corporation Of The Americas$1K
  • Roche Diagnostics Corporation$87

What the payments were for

  • Consulting fees$30,27195%
  • Travel & lodging$1,0843%
  • Food & beverage$3491%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,704 in reported general payments places this provider in the 95th percentile of 510 anatomic pathology & clinical pathology providers in Florida.

See all anatomic pathology & clinical pathology providers in Florida

Medicare billing

Part B allowed, 2024
$76,109
Medicare patients
675
Services billed
1,886

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →